 Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Fennec Pharmaceuticals Inc. NASDAQ: FENC resulting from allegations that Fennec may have issued materially misleading business information to the investing public. 